Telomir Pharmaceuticals Statistics
Total Valuation
TELO has a market cap or net worth of $116.37 million. The enterprise value is $115.20 million.
Important Dates
The last earnings date was Tuesday, February 4, 2025, after market close.
| Earnings Date | Feb 4, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
TELO has 29.76 million shares outstanding. The number of shares has increased by 8.18% in one year.
| Current Share Class | 29.76M |
| Shares Outstanding | 29.76M |
| Shares Change (YoY) | +8.18% |
| Shares Change (QoQ) | +0.17% |
| Owned by Insiders (%) | 17.89% |
| Owned by Institutions (%) | 10.07% |
| Float | 17.62M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 180.98 |
| P/TBV Ratio | 180.97 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.94, with a Debt / Equity ratio of 0.15.
| Current Ratio | 1.94 |
| Quick Ratio | 1.86 |
| Debt / Equity | 0.15 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -2.82 |
Financial Efficiency
Return on equity (ROE) is -810.18% and return on invested capital (ROIC) is -318.60%.
| Return on Equity (ROE) | -810.18% |
| Return on Assets (ROA) | -250.96% |
| Return on Invested Capital (ROIC) | -318.60% |
| Return on Capital Employed (ROCE) | -1,903.81% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$1.84M |
| Employee Count | 9 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -56.56% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | -56.56% |
| 50-Day Moving Average | 4.63 |
| 200-Day Moving Average | 4.91 |
| Relative Strength Index (RSI) | 40.31 |
| Average Volume (20 Days) | 122,273 |
Short Selling Information
The latest short interest is 1.28 million, so 4.30% of the outstanding shares have been sold short.
| Short Interest | 1.28M |
| Short Previous Month | 1.31M |
| Short % of Shares Out | 4.30% |
| Short % of Float | 7.27% |
| Short Ratio (days to cover) | 11.75 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -12.24M |
| Pretax Income | n/a |
| Net Income | -16.53M |
| EBITDA | n/a |
| EBIT | -12.24M |
| Earnings Per Share (EPS) | -$0.56 |
Full Income StatementBalance Sheet
The company has $1.27 million in cash and $93,432 in debt, giving a net cash position of $1.17 million or $0.04 per share.
| Cash & Cash Equivalents | 1.27M |
| Total Debt | 93,432 |
| Net Cash | 1.17M |
| Net Cash Per Share | $0.04 |
| Equity (Book Value) | 643,037 |
| Book Value Per Share | 0.02 |
| Working Capital | 643,037 |
Full Balance SheetCash Flow
| Operating Cash Flow | -5.07M |
| Capital Expenditures | n/a |
| Free Cash Flow | -5.07M |
| FCF Per Share | -$0.17 |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |